Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.76+0.59 (+5.80%)
At close: 04:00PM EDT
10.83 +0.07 (+0.65%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.17
Bid0.00 x 1300
Ask0.00 x 1800
Day's range10.20 - 10.91
52-week range7.61 - 19.99
Avg. volume4,927,146
Market cap1.997B
Beta (5Y monthly)2.51
PE ratio (TTM)N/A
EPS (TTM)-1.07
Earnings date03 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est17.45
  • Zacks

    Strength Seen in BioCryst (BCRX): Can Its 5.5% Jump Turn into More Strength?

    BioCryst (BCRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  • Motley Fool

    Why BioCryst Pharmaceuticals Topped the Market Today

    BioCryst Pharmaceuticals (NASDAQ: BCRX) stock defied the market's gravity on Wednesday by rising incrementally. Although it was a challenging day for stocks in general, with the S&P 500 index sinking by over 1%, BioCryst landed in the black thanks to some encouraging regulatory news. Before market open, BioCryst announced that the Food and Drug Administration (FDA) has granted its BCX9250 investigational drug fast-track designation.

  • Motley Fool

    Why BioCryst Stock Lost Nearly 4% of Its Value Today

    The biotech whiffs on both revenue and profitability for its first quarter, and indicates more losses are in store.